Who we are
DIPG/DMG Center lead
Sabine Mueller, MD, Ph.D.,MAS serves as the Head of the Clinical Program of the DIPG/DMG . She also leads the Pediatric Brain Tumor Program at UCSF and the Pacific Pediatric Neuro-Oncology Consortium (www.pnoc.us)
Javad Nazarian, Prof. Ph.D. serves as the Head of the Translational Program of the DIPG/DMG Center Zurich
Dr. Stephanie Mathes, contributes to the DIPG/DMG Center Zurich at as project manager. Her main focus is to obtain regulatory approval for clinical trial opening and management of the program.
Dr. Nicolas Gerber is a pediatric neuro-oncologist and head of the Early Phase Clinical Trials Unit of the Department of Pediatric Oncology at the University Children’s Hospital of Zürich. He is PI of PNOC trials.
Dr. Ana Guerreiro Stücklin is a pediatric neuro-oncologist and physician scientist at the University Children’s Hospital in Zurich, and will act as Co-PI for PNOC trials.
Marion Rizo-Oberholzer is study nurse at the DIPG/DMG Center Zurich and takes care of our patients and families.
Sabine Holzapfel is study nurse at the DIPG/DMG Center Zurich and takes care of our patients and families.
Prof. Dr. Michael Grotzer is the Full Professor of Pediatrics at the Medical Faculty of the University of Zurich and the Director of the Medical Clinic as well as the Medical Director at the University Children’s Hospital Zurich. Professor Grotzer is the head of Neuro Oncology where the center is embedded.
Prof. Dr. Niklaus Krayenbühl is the Head of Pediatric Neurosurgery at University Children’s Hospital of Zürich and Senior Neurosurgeon at the Department of Neurosurgery, University Hospital of Zürich.
Sulayman Mourabit, PhD, serves as Operational Manager and Scientific Coordinator. In his new role, Dr. Mourabit will streamline various aspects of translational research including in vitro, in vivo, and drug screen experiments.
Sandra Laternser, MSc in Life Sciences is a research associate in Dr. Nazarian’s lab. She is working at the interface of clinic and research lab and investigating biomarkers of target drugs.
Bettina Kritzer, MSc in Life Sciences, is a research associate in Dr. Nazarian’s lab. She is working at the interface of clinic and research with a focus on establishing in vitro blood-brain barrier and drug screening assays.
Mehmet Ozdas, PhD. His area of expertise includes focused ultrasound, targeted drug delivery, neuromodulation, in-vivo electrophysiology and in-vivo micro-dialysis.
Erin Bonner is a PhD student in Dr. Nazarian’s lab and maps epigenetic landscapes of DMGs in order to identify novel mutations driving tumorigenesis.
Anne Kraus is pursuing her Medical Doctor (MD) thesis in our lab. She is working on the role of tumour suppressor mutations and possible pharmaceutical targeting.
Rachna Prasad is a master’s student at the University of Zurich majoring in Biology with a special focus on Cancer Biology.